Leading Neuroscience Expert Magali Haas Appointed CMO of Psilera Inc. Magali Haas, MD/PhD, brings over 25 years of neuroscience expertise to Psilera, enhancing their mission in neuropsychiatric treatments.

Leading Neuroscience Expert Magali Haas Appointed CMO of Psilera Inc. #USA #Tampa,_Florida #neuroplastogens #Psilera #Magali_Haas

Scott Rairigh Appointed as Psilera's Executive Vice President to Lead Corporate Development Scott Rairigh, a veteran in the healthcare sector, has joined Psilera to strengthen the company's corporate development and business strategies.

Scott Rairigh Appointed as Psilera's Executive Vice President to Lead Corporate Development #United_States #Tampa #Psilera #Scott_Rairigh #neuroplastogen

Psilera Partners with Hesperos for Groundbreaking Dementia Treatment Development In a landmark collaboration, Psilera and Hesperos aim to enhance preclinical modeling of PSIL-006, a promising therapy for frontotemporal dementia, utilizing cutting-edge technology.

Psilera Partners with Hesperos for Groundbreaking Dementia Treatment Development #United_States #Orlando #Psilera #Hesperos #PSIL-006

Psilera Hosts Groundbreaking Summit Fostering FTD Research and Collaboration Psilera's first FTD Research Summit unites top researchers and advocacy groups to accelerate neurodegeneration research and treatments.

Psilera Hosts Groundbreaking Summit Fostering FTD Research and Collaboration #United_States #Tampa #FTD #Psilera #Neurodegeneration